title: Severe carbamazepine toxicity induced by concurrent erythromycin therapy.
authors.forename: C R
authors.initials: CR
authors.lastname: Mota
authors.forename: C
authors.initials: C
authors.lastname: Carvalho
authors.forename: C
authors.initials: C
authors.lastname: Mota
authors.forename: P
authors.initials: P
authors.lastname: Ferreira
authors.forename: A
authors.initials: A
authors.lastname: Vilarinho
authors.forename: E
authors.initials: E
authors.lastname: Pereira
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002648:Child; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D010612:Pharyngitis / Q000097:blood / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D002220:Carbamazepine; D004917:Erythromycin